CCCC vs ETR · rev $35.6M vs P/E 28, rev $12.95B
C4 Therapeutics Inc (CCCC) versus Entergy Corporation (ETR) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
CCCC currently screens at market cap $425.7M. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Not investment advice. Open the CCCC and ETR stock pages for the full models.
Not investment advice.